Page last updated: 2024-10-23

bisacodyl and Cancer of Rectum

bisacodyl has been researched along with Cancer of Rectum in 1 studies

Bisacodyl: A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)

Research Excerpts

ExcerptRelevanceReference
"A total mesorectal excision for rectal cancer-although nerve- and sphincter-sparing-can give rise to significant bowel symptoms, commonly referred to as low anterior resection syndrome (LARS)."1.72Exploring the pathophysiology of LARS after low anterior resection for rectal cancer with high-resolution colon manometry. ( Asnong, A; D'Hoore, A; De Groef, A; Devoogdt, N; Geraerts, I; Tack, J, 2022)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Asnong, A1
Tack, J1
Devoogdt, N1
De Groef, A1
Geraerts, I1
D'Hoore, A1

Other Studies

1 other study available for bisacodyl and Cancer of Rectum

ArticleYear
Exploring the pathophysiology of LARS after low anterior resection for rectal cancer with high-resolution colon manometry.
    Neurogastroenterology and motility, 2022, Volume: 34, Issue:11

    Topics: Anal Canal; Bisacodyl; Colon; Humans; Manometry; Organ Sparing Treatments; Postoperative Complicatio

2022